Investigation of image-based lesion and kidney dosimetry protocols for 177Lu-PSMA-I & T therapy with and without a late SPECT/CT acquisition
177Lu-PSMA therapy has been successfully used to prolong the survival of patients with metastatic castration-resistant prostate cancer. Patient-specific dosimetry based on serial quantitative SPECT/CT imaging can...
Source: EJNMMI Physics - Category: Radiology Authors: Sandra Resch, Sarah Takayama Fouladgar, Mathias Zacherl, Gabriel T. Sheikh, Grigory Liubchenko, Mikhail Rumiantcev, Lena M. Unterrainer, Vera Wenter, Peter Bartenstein, Sibylle I. Ziegler, Harun Ilhan, Leonie Beyer, Guido B öning and Astrid Delker Tags: Original research Source Type: research
More News: Cancer | Cancer & Oncology | Mergers and Aquisitions | Physics | Prostate Cancer | Radiology | SPECT | Urology & Nephrology